Tianda Pharmaceuticals Faces Wider Mid-Year Losses

Tianda Pharmaceuticals Ltd. (HK:0455) has released an update.

Tianda Pharmaceuticals Ltd. reported lower revenues and a steeper loss for the first half of 2024, with revenue dropping to HK$156,073,000 from HK$303,484,000 in the previous year, and net losses increasing to HK$27,225,000 from HK$4,911,000. The company also experienced a total comprehensive loss of HK$41,924,000, exacerbated by other comprehensive losses related to changes in equity investment values and exchange rate fluctuations.

For further insights into HK:0455 stock, check out TipRanks’ Stock Analysis page.